Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological

Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]

The Middle East & Africa bioanalytical testing services market was valued at US$ 221.87 million in 2022 and is expected to reach US$ 435.80 million by 2030; it is estimated to grow at a CAGR of 8.8% from 2022 to 2030.

Rising Drug Discovery and Development Activities for Emerging and Rare Diseases Fuel the Middle East & Africa Bioanalytical Testing Services Market

Bioanalytical testing services are used for the quantitative estimation of drugs and their metabolites in biological fluids. This testing is performed in the early stages of the drug development. Various biotechnology companies are engaging in collaborations to accelerate R&D activities and scale them up on a global level. Several ongoing drug research studies have shown positive outcomes for effectively treating chronic disorders such as cancer, neurological disorders, and autoimmune disorders. An upsurge in the prevalence of such disorders, coupled with the increase in R&D activities, would create demand for bioanalytical testing services in the coming years. An increase in the incidence of rare disorders such as amyloidosis, adrenoleukodystrophy, and Ehlers-Danlos syndrome has further bolstered the R&D activities for the development of interventions against them, which has been generating the demand for specific bioanalytical testing services. According to the Food and Drug Administration (FDA), in 2022, the Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. Out of 37, 20 drugs were approved for rare diseases. Thus, the continuous efforts of drug companies to discover and develop drugs against rare and emerging diseases are expected to provide lucrative opportunities for the expansion of the bioanalytical testing service businesses during the forecast period.

Middle East & Africa Bioanalytical Testing Services Market Overview

The Middle East & Africa bioanalytical testing services market is segmented into UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Government initiatives to strengthen analytical testing capacities and growing number of drug approvals and clinical trials are catalyzing the bioanalytical testing services market in the Middle East & Africa. The increasing use and development of numerous macromolecules and biosimilars for various therapeutic areas and increased government spending to set up new laboratories are other factors accelerating the bioanalytical testing services market growth.

Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Bioanalytical Testing Services Market Segmentation

The Middle East & Africa bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Middle East & Africa bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Middle East & Africa bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Middle East & Africa bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Middle East & Africa bioanalytical testing services market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Middle East & Africa bioanalytical testing services market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioanalytical testing services market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioanalytical testing services market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution